The Senate Health, Education, Labor & Pensions Committee today held the third in a series of bipartisan hearings on how to make prescription drugs more affordable, which focused on recent recommendations from a National Academies of Sciences, Engineering and Medicine report. In a statement submitted to the committee in June, AHA urged Congress and the administration to address the rising cost of drugs, and offered specific recommendations to increase competition, innovation and transparency, promote payment for value, improve access and align incentives. In her opening remarks at today’s hearing, Committee Ranking Member Patty Murray (D-WA) criticized the administration for reducing Medicare payments for hospital outpatient drugs under the 340B drug savings program by nearly 30% effective Jan. 1. “Not only will this do absolutely nothing to combat high drug prices, it will result in less funding for safety net providers to provide critical services to low-income and vulnerable patients,” she said. Last month, AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals filed a federal lawsuit to prevent the payment cut.

Related News Articles

Headline
The Campaign for Sustainable Rx Pricing, for which AHA is a founding member, today launched a petition and digital ad urging drug companies to suspend their “…
Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
The Food and Drug Administration today released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and…
Headline
The House Ways and Means Health Subcommittee yesterday held a hearing on proposals to lower drug prices and promote new cures.  Witness Ge Bai, an…